Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Total Non-Current Liabilities of $1.2 billion for Q1 2026, up 31.26% year-over-year from $892.1 million in Q1 2025, and up 92.86% quarter-over-quarter from $607.1 million in Q4 2025.
Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Total Non-Current Liabilities data on file, last reported at $1.2 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $1.2 billion, up 31.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 31.26% YoY), and the FY2025 annual result was $607.1 million, up 27.12% from the prior year.
- Total Non-Current Liabilities climbed to $1.2 billion in Q1 2026 per STVN's latest filing, from $607.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.2 billion in Q1 2026 and troughed at $205.4 million in Q4 2022.
- A 5-year average of $758.5 million and a median of $785.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 107.26% in 2022 and fell as far as 24.75% in 2022.
- A 5-year view of Total Non-Current Liabilities shows it stood at $205.4 million in 2022, then jumped by 90.99% to $392.2 million in 2023, then advanced by 21.77% to $477.6 million in 2024, then advanced by 27.12% to $607.1 million in 2025, then soared by 92.86% to $1.2 billion in 2026.
- Business Quant data shows STVN's Total Non-Current Liabilities at $1.2 billion in Q1 2026, $607.1 million in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 607.14 Mn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 892.07 Mn |
| Dec 31, 2024 | 477.62 Mn |
| Sep 30, 2024 | 921.82 Mn |
| Jun 30, 2024 | 884.65 Mn |
| Mar 31, 2024 | 903.23 Mn |
| Dec 31, 2023 | 392.23 Mn |
| Sep 30, 2023 | 847.14 Mn |
| Jun 30, 2023 | 785.03 Mn |
| Mar 31, 2023 | 742.65 Mn |
| Dec 31, 2022 | 205.36 Mn |
| Sep 30, 2022 | 654.49 Mn |
| Jun 30, 2022 | 663.51 Mn |
| Mar 31, 2022 | 652.22 Mn |
| Dec 31, 2021 | 272.91 Mn |
| Sep 30, 2021 | 315.78 Mn |
| Jun 30, 2021 | 355.10 Mn |